Ruchin Kansal is the Executive Director, Organized Customer Collaborations at Boehringer Ingelheim Pharmaceuticals, Inc. In this role, he is working on achieving the objective of improving lives of patients and their families through strategic collaborations with large US payers and providers. Such collaborations are focused on driving product innovation, clinical trial innovation, care innovation grounded in collaborative real world evidence generation, and provider and patient engagement innovation utilizing traditional and digital health technologies.
Mr. Kansal has global experience as an executive, strategic advisor and an entrepreneur in biopharmaceutical and medical devices industry. Prior to Boehringer Ingelheim, he held leadership roles at Campbell Alliance, Deloitte Consulting and Cap Gemini Ernst & Young. He holds an undergraduate degree in Architecture from Indian Institute of Technology (IIT), Roorkee and MBA from NYU-Stern.